PMRC 2026 Reflections

PMRC 2026 Reflections

Authors: Sunny Shah, Head of US Insights, Alexandra Hunt, Research Manager, Beyond Blue Data is EVERYWHERE Clients are sitting on more data than ever, from an expanding range of sources. This is reshaping how they prioritize insights needs, allocate budgets, and...
Breast Cancer 2026: Navigating the forks in the road

Breast Cancer 2026: Navigating the forks in the road

Author: Siobhan Davies, Research Consultant, Beyond Blue 2025 delivered a remarkable volume of breast cancer data, with striking results across multiple subtypes and treatment settings. As we move into 2026, these advances need to find their place, and physicians are...
ESMO 2025 Reflections

ESMO 2025 Reflections

Four potentially practice-changing bladder cancer papers This year’s ESMO congress delivered a wealth of impactful data across the bladder cancer spectrum, from muscle-invasive to metastatic disease. Here are four standout studies with potential to reshape clinical...
ESMO 2025: Ones to watch

ESMO 2025: Ones to watch

Explore the headlines set to surface at ESMO 2025. ADCs make their move into early-stage disease Drugs like Enhertu and Padcev, already headline-makers in metastatic disease, are now making waves in early-stage settings. DESTINY-Breast05, DESTINY-Breast11, and...